{"id":"td-impfstoff-merieux","safety":{"commonSideEffects":[{"rate":"null","effect":"Injection site pain"},{"rate":"null","effect":"Fatigue"},{"rate":"null","effect":"Headache"}]},"_chembl":null,"_fixedAt":"2026-03-30T12:25:45.992127","_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"It works by introducing inactivated diphtheria and tetanus toxins to the body, which triggers an immune response and helps the body develop antibodies to fight these diseases. This immune response can provide long-term protection against diphtheria and tetanus.","oneSentence":"Td-Impfstoff Merieux is a vaccine that stimulates the body's immune response to diphtheria and tetanus.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:53:55.040Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Prevention of diphtheria and tetanus"}]},"_fixedFields":["pubmed(1)"],"trialDetails":[{"nctId":"NCT05480462","phase":"PHASE3","title":"Immunogenicity and Safety of Vaccine Against Tetanus and Diphtheria.","status":"UNKNOWN","sponsor":"IBSS Biomed S.A.","startDate":"2022-12-12","conditions":"Diphtheria, Tetanus","enrollment":200}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":1,"recentPublications":[{"date":"2000 Jun","pmid":"10877165","title":"Immunogenicity and safety of a trivalent tetanus, low dose diphtheria, inactivated poliomyelitis booster compared with a standard tetanus, low dose diphtheria booster at six to nine years of age. Munich Vaccine Study Group.","journal":"The Pediatric infectious disease journal"}],"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"Td-Impfstoff Merieux","genericName":"Td-Impfstoff Merieux","companyName":"IBSS Biomed S.A.","companyId":"ibss-biomed-s-a","modality":"Biologic","firstApprovalDate":"","aiSummary":"Td-Impfstoff Merieux is a vaccine that stimulates the body's immune response to diphtheria and tetanus. Used for Prevention of diphtheria and tetanus.","enrichmentLevel":3,"visitCount":2,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}